Maternal asthma: when eosinophils disrupt the development of the child's heart and kidneys
AI-generated hypothesis · Pre-publication · To be tested experimentally
Table of contents — full brief
- Hypothesis and mechanismCausal chain, key assumptions, residual unknowns
- State of the artVerified references and counter-evidence (DOIs)
- Falsifiable predictionsQuantitative bounds, statistical tests, H0
- Experimental protocolThree phases — in silico → minimal → full
- Impact analysisNovelty, residual gaps, available data
- Panel reviewFive personas + meta-review
Verified references
5 of 14 references- DOI: 10.3390/ijms25063298 ↗
The Renin–Angiotensin System and Cardiovascular–Kidney–Metabolic Syndrome: Focus on Early-Life Programming
2024 - DOI: 10.1161/HYP.0000000000000227 ↗
Appraising the Preclinical Evidence of the Role of the Renin-Angiotensin-Aldosterone System in Antenatal Programming of Maternal and Offspring Cardiovascular Health Across the Life Course: Moving the Field Forward: A Scientific Statement From the American Heart Association
2023 - DOI: 10.1038/s41419-018-0701-z ↗
Increased H3K27ac level of ACE mediates the intergenerational effect of low peak bone mass induced by prenatal dexamethasone exposure in male offspring rats
2018 - DOI: 10.1038/s41569-023-00984-x ↗
Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease
2024 - DOI: 10.3389/fimmu.2020.580598 ↗
Could Arachidonic Acid-Derived Pro-Resolving Mediators Be a New Therapeutic Strategy for Asthma Therapy?
2020
+ 9 more references
Detailed panel scores
The protocol is structured into three progressive phases (in silico, minimal validation, full protocol) with explicit GO/NO-GO criteria and predefined pivots, which limits the commitment of resources to a non-viable hypothesis and enables early falsifiability.
The hypothesis creatively integrates two hitherto largely disjoint fields of research: eosinophil/SPM biology and fetal programming of the RAS, by proposing an eosinophil–RAS axis conserved at the maternal–fetal interface. This positioning is original and generates testable predictions (for example, restoration by resolvin D1 or losartan).
The hypothesis incorporates an explicit, falsifiable multi-step causal chain, with quantitative predictions and well-specified methods (LC-MS/MS, ChIP-qPCR, telemetry), which facilitates refutation.
The perinatal predictive diagnostics market for paediatric cardio-reno-metabolic (CKM) disease is growing, driven by players such as Natera (Panorama test), Labcorp, Quest Diagnostics, and start-ups such as Mirvie (placental RNA diagnostics). A risk test based on the placental eosinophil–RAS axis could be positioned within prenatal screening for maternal asthma (prevalence 8–13% of pregnancies) and CKM risks, with a potential price of €500–1,500 per test.
Original mechanistic and testable hypothesis: the eosinophil–RAS–SPM axis in CKM fetal programming has never been explored, which offers strong potential for a finding and for publication in top-tier journals (Nature Medicine, Cell Metabolism).
Receive the next SPORE hypotheses
Once or twice a month, in your inbox. No spam, one-click unsubscribe.
Your data stays private. No third-party sharing. GDPR-compliant.